Yuqi Jiang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Nlrp Inflammasome

Top Venues

Journal of medicinal chemistry

Journal of the American Chemical Society

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kaijin Zhang, Junyu Liu, Yuqi Jiang, Simin Sun, Rongrong Wang, Jingxian Sun, Chuanteng Ma, Yinghan Chen, Wenxue Wang, Xuewen Hou, Tianjiao Zhu, Guojian Zhang, Qian Che, Joanne E Harvey, Ming Liu, De-Hai Li
Sorbremnoids A and B: NLRP3 Inflammasome Inhibitors Discovered from Spatially Restricted Crosstalk of Biosynthetic Pathways. Journal of the American Chemical Society (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Wanting Hao, Leyan Wang, Tongqiang Xu, Geng Jia, Yuqi Jiang, Chong Qin, Xiaoyang Li
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax. Marine drugs 22 (6) (2024)
Kaijin Zhang, Junyu Liu, Yuqi Jiang, Simin Sun, Rongrong Wang, Jingxian Sun, Chuanteng Ma, Yinghan Chen, Wenxue Wang, Xuewen Hou, Tianjiao Zhu, Guojian Zhang, Qian Che, Joanne E Harvey, Ming Liu, De-Hai Li
Sorbremnoids A and B: NLRP3 Inflammasome Inhibitors Discovered from Spatially Restricted Crosstalk of Biosynthetic Pathways. Journal of the American Chemical Society 146 (26) (2024)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry 66 (6) (2023)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry 66 (6) (2023)
Liang Zhang, Kangjing Qi, Jie Xu, Yan Xing, Xuejian Wang, Ling Tong, Zengguo He, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine. Journal of medicinal chemistry (2023)
Jian Zhang, Simin Sun, Jinyu Liu, Liang Zhang, Di Guo, Naixin Zhang, Jun Zhao, Dexin Kong, Tongqiang Xu, Xuejian Wang, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules (Basel, Switzerland) 28 (17) (2023)
Simin Sun, Zhuoyue Li, Chao Huang, Jinyu Liu, Qixin Yu, Xiaolin Jiang, Kairui Yue, Jianchun Zhao, Tongqiang Xu, Yan-Kai Liu, Xiaoyang Li, Chong Qin, Yuqi Jiang
Discovery of Novel 2,3-Dihydro-1 H -indene-5-sulfonamide NLRP3 Inflammasome Inhibitors Targeting Colon as a Potential Therapy for Colitis. Journal of medicinal chemistry (2023)
Zhuoyue Li, Yiming Chen, Xiaolin Jiang, Penghui Lu, Chengli Wang, Zhimin Li, Xinyue Yu, Zixuan Yang, Shumin Ma, Shanshan Du, Zhengfu Tai, Xiaoyang Li, Siqi Zhang, Yuqi Jiang, Chong Qin
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis. Journal of medicinal chemistry (2023)